{"DataElement":{"publicId":"7649041","version":"1","preferredName":"Melanoma Growth Phase Outcome","preferredDefinition":"A secondary study finding which documents the morphologic architectural pattern of the atypical, neoplastic melanocyte cell spread of a melanoma.","longName":"7649036v1.0:7649038v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7649036","version":"1","preferredName":"Melanoma Growth Phase","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain._The morphologic architectural pattern in which the tumor cells spread.","longName":"3108463v1.0:7649034v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"3108463","version":"1","preferredName":"Melanoma","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004","longName":"C3224","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"888ED2DC-38AD-7A5E-E040-BB89AD4317F2","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7649034","version":"1","preferredName":"Growth Phase","preferredDefinition":"The morphologic architectural pattern in which the tumor cells spread.","longName":"C159261","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Growth Phase","conceptCode":"C159261","definition":"The morphologic architectural pattern in which the tumor cells spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16FEFC2-4F41-01B9-E053-4EBD850AEF4C","latestVersionIndicator":"Yes","beginDate":"2021-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-03","modifiedBy":"ONEDATA","dateModified":"2021-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16FEFC2-4F52-01B9-E053-4EBD850AEF4C","latestVersionIndicator":"Yes","beginDate":"2021-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-03","modifiedBy":"SOKKERL","dateModified":"2023-09-24","changeDescription":null,"administrativeNotes":"Admin: 9/23/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7649038","version":"1","preferredName":"Growth Phase Outcome","preferredDefinition":"The morphologic architectural pattern in which the tumor cells spread._The result of an action.","longName":"7649038v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Radial","valueDescription":"Radial Growth Phase","ValueMeaning":{"publicId":"4265004","version":"1","preferredName":"Radial Growth Phase","longName":"4265004v1.00","preferredDefinition":"A morphologic architectural pattern in which the tumor cells spread horizontally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radial Growth Phase","conceptCode":"C35897","definition":"A morphologic architectural pattern in which the tumor cells spread horizontally.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-4111-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C16FC089-570F-01AE-E053-4EBD850AE771","beginDate":"2021-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-03","modifiedBy":"ONEDATA","dateModified":"2021-05-03","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":"Indeterminate Growth Phase","ValueMeaning":{"publicId":"7649040","version":"1","preferredName":"Indeterminate Growth Phase","longName":"7649040","preferredDefinition":"A response that the growth phase is undetermined.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate Growth Phase","conceptCode":"C159263","definition":"A response that the growth phase is undetermined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16FC089-56CD-01AE-E053-4EBD850AE771","latestVersionIndicator":"Yes","beginDate":"2021-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-03","modifiedBy":"ONEDATA","dateModified":"2021-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C16FC089-56E6-01AE-E053-4EBD850AE771","beginDate":"2021-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-03","modifiedBy":"ONEDATA","dateModified":"2021-05-03","deletedIndicator":"No"},{"value":"Vertical","valueDescription":"Vertical Growth Phase","ValueMeaning":{"publicId":"4264972","version":"1","preferredName":"Vertical Growth Phase","longName":"4264972v1.00","preferredDefinition":"A morphologic architectural pattern in which the tumor cells spread vertically.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vertical Growth Phase","conceptCode":"C35898","definition":"A morphologic architectural pattern in which the tumor cells spread vertically.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3C80-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C16FC089-56FA-01AE-E053-4EBD850AE771","beginDate":"2021-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-03","modifiedBy":"ONEDATA","dateModified":"2021-05-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7649037","version":"1","preferredName":"Growth Phase Outcome","preferredDefinition":"The morphologic architectural pattern in which the tumor cells spread.:The result of an action.","longName":"C159261:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Growth Phase","conceptCode":"C159261","definition":"The morphologic architectural pattern in which the tumor cells spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16FC089-56A2-01AE-E053-4EBD850AE771","latestVersionIndicator":"Yes","beginDate":"2021-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-03","modifiedBy":"ONEDATA","dateModified":"2021-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16FC089-56B3-01AE-E053-4EBD850AE771","latestVersionIndicator":"Yes","beginDate":"2021-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-03","modifiedBy":"SOKKERL","dateModified":"2023-09-24","changeDescription":null,"administrativeNotes":"2023.8.14 Update PV def for 'No Value Exists'. ak Admin: 9/23/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7634324","version":"1","longName":"CM Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Growth Phase","type":"Preferred Question Text","description":"Growth Phase","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16FC089-5728-01AE-E053-4EBD850AE771","latestVersionIndicator":"Yes","beginDate":"2021-05-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-03","modifiedBy":"SOKKERL","dateModified":"2023-09-24","changeDescription":"7/28/21 jk upd sys gen def.","administrativeNotes":"Admin: 9/23/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"}}